Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Synairgen Share News (SNG)
SNG Share
Price
SNG Share
News
SNG Share
Chat
SNG Share
Trades103
SNG
Live RNS
SNG Share
Charts
SNG Broker
Ratings
SNG Directors
Deals
SNG Financial
Diary
SNG
Fundamentals
SNG Short
Positions
SNG
Media
SNG Company
Research
SNG Company
Timeline
- There is currently no data for SNG
Synairgen News
Synairgen promotes Marcin Mankowski to chief medical officer
(Alliance News) - Synairgen PLC on Tuesday promoted Marcin Mankowski to chief medical officer, effective immediately.
IN BRIEF: Synairgen narrows interim loss on reduced R&D spending
Synairgen PLC - Southampton, England-based drug discovery and biotechnology firm developing SNG001 antiviral treatment for lung infections - Pretax lo...
EARNINGS SUMMARY: Synairgen loss narrows; aims to develop SNG001
(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Thursday and not separately reported by Allian...
TRADING UPDATES: SulNOx raises funds; Synairgen shares trial results
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
Synairgen test results positive but not "statistically significant"
(Alliance News) - Synairgen PLC on Tuesday said it had received positive data from its ACTIV-2 Phase 2 trial for its antiviral treatment.
Synairgen posts positive results for phase 2 trial with SNG001 against Covid-19
(Sharecast News) - Synairgen announced positive results for its inhaled antiviral protein treatment interferon beta against Covid-19.
Follow the stocks
